Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan

Jing-Jou Yan, Wen-Chien Ko, Hsiu-Mei Wu, Shu-Huei Tsai, Chin-Luan Chuang, Jiunn-Jong Wu
Jing-Jou Yan
1Department of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Chien Ko
2Internal Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiu-Mei Wu
3Medical Technology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Huei Tsai
1Department of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chin-Luan Chuang
1Department of Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiunn-Jong Wu
3Medical Technology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jjwu@mail.ncku.edu.tw
DOI: 10.1128/JCM.42.11.5337-5340.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Among 99 clinical Klebsiella pneumoniae isolates resistant to cefoxitin and extended-spectrum cephalosporins, coexistence of AmpC (DHA-1, CMY-2, or CMY-8) and extended-spectrum β-lactamases (CTX-M and/or SHV) was detected in a total of 35. The remainder produced AmpC (n = 42), extended-spectrum β-lactamases (n = 9), metallo-β-lactamases (n = 2), or none of these enzymes (n = 11). Phenotypic characteristics of these isolates were demonstrated.

The majority of β-lactamases that confer resistance to extended-spectrum cephalosporins on Klebsiella pneumoniae are Ambler's molecular class A extended-spectrum β-lactamases (ESBLs) (3). β-Lactamases of molecular classes B and C, also termed metallo-β-lactamases (MBLs) and AmpC enzymes, respectively, provide a broader spectrum of resistance than ESBLs and have also been identified in K. pneumoniae (4, 6, 11). Unlike ESBLs, AmpC and MBLs are poorly inhibited by β-lactamase inhibitors and are active against cephamycins (4, 6, 11). AmpC enzymes are usually less active against cefepime and cefpirome than ESBLs and MBLs (11), and the activity of MBLs can be blocked by chelating agents (6). On the basis of the characteristics of these β-lactamases, various phenotypic detection methods have been proposed previously (1, 3, 5, 7, 11, 14, 20); however, coexistence of different classes of β-lactamases in a single bacterial isolate may pose diagnostic challenges.

We have detected AmpC enzymes and MBLs in cephamycin- and extended-spectrum cephalosporin-resistant K. pneumoniae (CECR-KP) isolates in Taiwan (16-19). Recently, the number of CECR-KP isolates that had resistance phenotypes that were slightly different than those previously reported for our AmpC and MBL producers seemed to be on the increase in our laboratory. These isolates were characterized in the present study, and the complexity of CECR-KP isolates was determined.

After excluding the previously reported isolates (17-19), a total of 99 nonreplicate CECR-KP isolates consecutively collected between January 1999 and June 2002 at the National Cheng Kung University Hospital, a 900-bed teaching hospital, were analyzed. These isolates were considered possible ESBL producers in accordance with the results of initial screening tests proposed by the National Committee for Clinical Laboratory Standards (NCCLS) and demonstrated resistance to cefoxitin in the standard disk diffusion tests (8).

The disk diffusion confirmatory tests for the presence of ESBLs were performed in accordance with NCCLS guidelines (8). The double-disk synergy test was also performed by placing a disk of cefepime (30 μg) at a distance of 20 mm (center to center) from a disk containing amoxicillin and clavulanic acid (20 and 10 μg) (14). The method has been reported to be sensitive in the detection of ESBLs in enterobacteria that have intrinsic AmpC enzymes (14). The three-dimensional extraction method proposed by Coudron et al. (5) was used with cefoxitin disks to detect AmpC-producing isolates. A modified Arakawa's double-disk test for detecting MBLs was performed by placing disks of ceftazidime and cefepime (30 μg each) with and without clavulanic acid (10 μg) at a distance of 25 mm (center to center) from a disk containing 2-mercaptopropionic acid (Sigma Chemical Co., St. Louis, Mo.) (1, 20). An enhanced zone of inhibition between the 2-mercaptopropionic acid disk and any one of the four drug disks was interpreted as a positive test result (20). The 99 CECR-KP isolates were divided into five major groups according to the results of the screening tests for AmpC and MBLs and the double-disk tests with cefepime for ESBLs (Table 1). Group 1 and 2 isolates were further subgrouped according to the results of the NCCLS confirmatory tests for the presence of ESBLs.

The expression of β-lactamases was detected by isoelectric focusing and the enzyme inhibition assay as described previously (16). PCR detection of blaTEM, blaSHV, blaCTX-M-1-related, blaCTX-M-9-related, blaCMY-8, blaCMY-2, blaDHA-1-related, and blaIMP-8 genes was performed with previously reported oligonucleotide primers (10, 12, 15-18). The PCR-NheI method was used to discriminate between blaSHV-ESBL and blaSHV-non-ESBL genes (10). Amplification products of the other genes obtained from two independent PCRs were purified and sequenced twice. pIs of β-lactamases and the corresponding β-lactamase types determined by PCR assays are shown in Table 2. In the PCR-NheI test, coexistence of an undigested band and digested bands on an agarose gel for a single isolate with pI 7.6 and 8.2 β-lactamases suggested coproduction of an SHV-1-related non-ESBL and an SHV-5-related ESBL (4). MICs of various antimicrobial agents for the 99 CECR-KP isolates were determined by the standard agar dilution method with Escherichia coli ATCC 25922 as the control strain (9). The antimicrobial agents tested and the results are shown in Table 2.

Group 1 isolates were positive for the AmpC screening tests only. Subgroup 1b isolates demonstrated reduced zone diameters for ceftazidime and cefotaxime with clavulanic acid versus those for ceftazidime and cefotaxime tested alone in the ESBL confirmatory tests, and they were all found to be DHA-1 producers. These data are consistent with the inducibility of blaDHA-1 (2, 18). Subgroup 1a isolates were all CMY-2 producers.

Coproduction of AmpC and ESBLs in group 2 isolates was suggested by the positive results of the AmpC screening tests and the double-disk tests for ESBLs. DHA-1 and CTX-M-type ESBLs were detected in all subgroup 2a and 2b isolates; moreover, SHV-type ESBLs were detected in subgroup 2b isolates. The presence of CTX-M-type ESBLs might be responsible for markedly increased zone diameters of cefotaxime disks plus clavulanic acid in the ESBL confirmatory tests; the presence of SHV-type ESBLs in subgroup 2b isolates might mask the effect of DHA-1 on ceftazidime disks. The changes in the zone diameters of drug disks in the ESBL confirmatory tests were less evident for subgroup 2c isolates, and only 9 of 19 (47.4%) subgroup 2c isolates could be classified as ESBL producers by the ESBL confirmatory tests. Subgroup 2c isolates were found to coproduce an AmpC enzyme (DHA-1, CMY-2, or CMY-8) and one or two ESBLs (CTX-M and/or SHV-type ESBLs). The phenotypic characteristics of subgroup 2c and 1a isolates were similar except that group 2c isolates gave positive results with the double-disk tests with cefepime and demonstrated reduced susceptibilities to cefepime (Table 2).

Group 3 included two IMP-8-type MBL producers. The false-positive results given by the two isolates in the AmpC screening tests should be due to the hydrolysis of cefoxitin by IMP-8. One of these isolates also produced an SHV-type ESBL and showed a much higher aztreonam MIC than the other isolate that had no ESBL (64 versus 0.25 μg/ml).

No AmpC enzymes were detected by isoelectric focusing and PCR assays in group 4 and 5 isolates. Production of ESBLs was inferred by the phenotypic detection methods, and CTX-M or SHV ESBLs were detected in group 4 isolates. Reduced susceptibilities to cefoxitin in group 4 and 5 isolates could be due to mechanisms other than production of β-lactamases.

Pulsed-field gel electrophoresis of DNA samples from 24 isolates randomly selected from the DHA-1-producing isolates was performed after cleavage with the restriction endonuclease XbaI (New England Biolabs, Beverly, Mass.) (13, 16), and the results were interpreted according to Tenover's criteria (13). A total of 18 major patterns were obtained among the 24 isolates (Table 2). Four isolates coproducing DHA-1 and ESBLs and three isolates producing DHA-1 alone had similar patterns (patterns Ia to Id). Different patterns were also obtained among isolates with the same β-lactamase contents.

In conclusion, the present study demonstrated the complexity of CECR-KP isolates at a Taiwanese university hospital. The molecular typing analyses suggest that the complexity of these isolates could be due to stepwise acquisition of resistance determinants and acquisition of the same resistance determinants by different clones. Diagnostic problems posed by coexistence of different classes of β-lactamases in a single bacterial isolate could be solved by the combined use of various phenotypic detection methods. For epidemiologic purposes, the combined use of these phenotypic methods may be needed for microbiology laboratories in which high rates of CECR-KP isolates produce multiple β-lactamases.

View this table:
  • View inline
  • View popup
TABLE 1.

Categorization of CECR-KP isolates according to the results of phenotypic detection methods for AmpC, ESBLs, and MBLs

View this table:
  • View inline
  • View popup
TABLE 2.

Results of isoelectric focusing, β-lactamase characterization, susceptibility testing, and pulsed-field gel electrophoresis analysis

ACKNOWLEDGMENTS

This work was supported by grant NSC 92-2320-B-006-088 from the National Science Council, Taipei, Taiwan.

FOOTNOTES

    • Received 3 March 2004.
    • Returned for modification 13 July 2004.
    • Accepted 30 July 2004.
  • Copyright © 2004 American Society for Microbiology

REFERENCES

  1. 1.↵
    Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fugiwara, and M. Goto. 2000. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol.38:40-43.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Barnaud, G., G. Arlet, C. Verdet, O. Gaillot, P. H. Lagrange, and A. Philippon. 1998. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii.Antimicrob. Agents Chemother.42:2352-2358.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev.14:933-951.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother.39:1211-1233.
    OpenUrlFREE Full Text
  5. 5.↵
    Coudron, P. E., E. S. Moland, and K. S. Thomson. 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol.38:1791-1796.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Livermore, D. M., and N. Woodford. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol.5:489-495.
    OpenUrl
  7. 7.↵
    Manchanda, V., and N. P. Singh. 2003. Occurrence and detection of AmpC β-lactamases among gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J. Antimicrob. Chemother.51:415-418.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests, 8th ed. Approved standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  9. 9.↵
    National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  10. 10.↵
    Nüesch-Inderbinen, M. T., H. Hächler, and F. H. Kayser. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbiol. Infect. Dis.15:398-402.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother.46:1-11.
    OpenUrlFREE Full Text
  12. 12.↵
    Saladin, M., V. T. B. Cao, T. Lambert, J.-L. Donay, J.-L. Herrmann, Z. Ould-Hocine, C. Verdit, F. Delisle, A. Philippon, and G. Arlet. 2002. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett.209:161-168.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol.33:2233-2239.
    OpenUrlFREE Full Text
  14. 14.↵
    Tzelepi, E., P. Giakkoupi, D. Sofianou, V. Loukova, A. Kemeroglou, and A. Tsakris. 2000. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.J. Clin. Microbiol.38:542-546.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Winokur, P. L., A. Brueggemann, D. L. Desalvo, L. Hoffmann, M. D. Apley, E. K. Uhlenhopp, M. A. Pfaller, and G. V. Doern. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC β-lactamase. Antimicrob. Agents Chemother.44:2777-2783.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Yan, J.-J., S.-M. Wu, S.-H. Tsai, J.-J. Wu, and I.-J. Su. 2000. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamase and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob. Agents Chemother.44:1438-1442.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Yan, J.-J., W.-C. Ko, S.-H. Tsai, H.-M. Wu, and J.-J. Wu. 2001. Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying blaIMP-8 in a university medical center in Taiwan. J. Clin. Microbiol.39:4433-4439.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Yan, J.-J., W.-C. Ko, Y.-C. Jung, C. L. Chuang, and J.-J. Wu. 2002. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 β-lactamase in a university hospital in Taiwan. J. Clin. Microbiol.40:3121-3126.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Yan, J.-J., W.-C. Ko, C.-H. Chiu, S.-H. Tsai, H.-M. Wu, and J.-J. Wu. 2003. Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2 cephalosporinase, Taiwan. Emerg. Infect. Dis.9:323-328.
    OpenUrlPubMedWeb of Science
  20. 20.↵
    Yan, J.-J., J.-J. Wu, S.-H. Tsai, and C.-L. Chuang. 2004. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagn. Microbiol. Infect. Dis.49:5-11.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan
Jing-Jou Yan, Wen-Chien Ko, Hsiu-Mei Wu, Shu-Huei Tsai, Chin-Luan Chuang, Jiunn-Jong Wu
Journal of Clinical Microbiology Nov 2004, 42 (11) 5337-5340; DOI: 10.1128/JCM.42.11.5337-5340.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Complexity of Klebsiella pneumoniae Isolates Resistant to Both Cephamycins and Extended-Spectrum Cephalosporins at a Teaching Hospital in Taiwan
Jing-Jou Yan, Wen-Chien Ko, Hsiu-Mei Wu, Shu-Huei Tsai, Chin-Luan Chuang, Jiunn-Jong Wu
Journal of Clinical Microbiology Nov 2004, 42 (11) 5337-5340; DOI: 10.1128/JCM.42.11.5337-5340.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cephalosporin resistance
Hospitals, Teaching
Klebsiella pneumoniae
beta-lactamases

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X